165 Astrocyte–Glioblastoma Metabolic Interactions at the Invasive Margin Reveal Therapeutic Vulnerabilities

Clicks: 18
ID: 326672
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #159 of 286 articles by views in journal of neuro-oncology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 286 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Introduction Glioblastoma is an aggressive brain tumour that, despite multimodal treatment, almost always recurs. Infiltrative tumour cells within the brain microenvironment are thought to drive recurrence and are supported by surrounding non-cancerous brain cells. Among these, astrocytes, the most abundant glial cells in the brain, play key roles in regulating metabolic homeostasis. The metabolic dependencies underpinning astrocyte–glioblastoma interactions remain poorly defined. Identifying targetable metabolic pathways within this niche may inform new therapeutic strategies. Method Patient-derived glioblastoma invasive margin cells and human cortical astrocytes were cultured individually and in co-culture to model tumour–microenvironment interactions. Single-cell metabolic profiling was performed using microscopy-guided atmospheric pressure matrix-assisted laser desorption/ionisation (AP-MALDI) imaging mass spectrometry at 10 μm spatial resolution. Complementary liquid chromatography–mass spectrometry enabled pathway-level analysis. Stable isotope tracing using labelled metabolic precursors was then used to investigate metabolite utilisation and intercellular exchange in selected pathways. Pharmacological inhibitors targeting amino acid transport and metabolism were applied to assess therapeutic relevance. Results Glioblastoma invasive margin cells cultured with astrocytes showed distinct metabolic adaptations, including changes in amino acids and lipid metabolism consistent with microenvironment-driven metabolic reprogramming. Stable isotope tracing demonstrated engagement of tyrosine and phenylalanine pathways, supporting metabolic exchange and pathway utilisation within the tumour–astrocyte microenvironment. Pharmacological targeting of amino acid transport and downstream metabolic processes resulted in differential functional responses. Conclusions These findings demonstrate that astrocyte–glioblastoma metabolic interactions create targetable dependencies within the tumour microenvironment. Therapeutic targeting of tumour–microenvironment metabolic crosstalk may represent a promising strategy to disrupt tumour adaptation and improve treatment approaches for glioblastoma recurrence.
Reference Key
openalex_W7204439191 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Une Kontrimaite, Phoebe McCrorie, Carver Wong, Sandra Martinez Jarquin, Harry Porter, Stuart Smith, Dong-Hyun Kim, Ruman Rahman
Are you one of these authors? Claim your profile
Journal journal of neuro-oncology
Year 2026
DOI
10.1093/neuonc/noag172.061
URL
https://academic.oup.com/neuro-oncology/article-pdf/28/Supplement_1/noag172.061/70805911/noag172.061.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.